1. Kojic M, Milosevic M, Simic V, Milicevic B, Terracciano R, Filgueira CS. On the generality of the finite element modeling physical fields in biological systems by the multiscale smeared concept (Kojic transport model). Heliyon. 2024 Feb 23;10(5):e26354. doi: 10.1016/j.heliyon.2024.e26354. PMID: 38434281; PMCID: PMC10907537.
  2. Terracciano R, Carcamo-Bahena Y, Royal ALR, Messina L, Delk, Butler EB, Demarchi D, Grattoni A, Wang Z, Cristini V, Dogra P, Filgueira CS. Zonal Intratumoral Delivery of Nanoparticles Guided by Surface Functionalization. Langmuir 2022. doi:  10.1021/acs.langmuir.2c02319
  3. Mathuria N, Royal ALR, Enterría-Rosales J, Carcamo-Bahena Y, Terracciano R, Dave A, Valderrabano M, Filgueira CS. Near-Infrared Sensitive Nanoparticle Mediated Photothermal Ablation of Ventricular Myocardium. Heart Rhythm 2022 May 11;S1547-5271(22)01962-2. doi: 10.1016/j.hrthm.2022.05.006
  4. Terracciano R, Carcamo-Bahena Y, Royal ALR, Demarchi D, Labis JS, Harris JD, Weiner BK, Gupta N, Filgueira CS. Quantitative high-resolution 7T MRI to assess longitudinal changes in articular cartilage after anterior cruciate ligament injury in a rabbit model of post-traumatic osteoarthritis. Osteoarthritis and Cartilage Open 2022, 4(2), 100259. doi: 10.1016/j.ocarto.2022.100259
  5. Terracciano R, Carcamo-Bahena Y, Butler EB, Demarchi D, Grattoni A, Filgueira CS. Hyaluronate-Thiol Passivation Enhances Gold Nanoparticle Peritumoral Distribution When Administered Intratumorally in Lung Cancer. Biomedicines 2021, 9, 1561. doi: 10.3390/biomedicines9111561
  6. Terracciano R, Zhang A, Simeral ML, Demarchi D, Hafner JH, Filgueira CS. Improvements in Gold Nanorod Biocompatibility with Sodium Dodecyl Sulfate Stabilization. Journal of Nanotheranostics. 2021; 2(3):157-173. doi: 10.3390/jnt2030010
  7. Wang DK, Rahimi M, Filgueira CS. Nanotechnology Applications for Cardiovascular Disease Treatment: Current and Future Perspectives. Nanomedicine: Nanotechnology, Biology, and Medicine. 2021 Jun;34:102387. doi: 10.1016/j.nano.2021.102387
  8. Terracciano R, Zhang A, Butler EB, Demarchi D, Hafner JH, Grattoni A, Filgueira CS. Effects of Surface Protein Adsorption on the Distribution and Retention of Intratumorally Administered Gold Nanoparticles. Pharmaceutics 2021, 13(2), 216. doi: 10.3390/pharmaceutics13020216
  9. Karaboga H, Huang W, Srivastava S, Widmann S, Addanki S, Gamage KT, Mazhar Z, Ebalunode JO, Briggs JM, Gustafsson J, Filgueira CS, Gilbertson SR, Lin CY. Screening of Focused Compound Library Targeting Liver X Receptors in Pancreatic Cancer Identified Ligands with Inverse Agonist and Degrader Activity. ACS Chem. Biol. 2020 Oct 19; 15(11):2916-2928. doi: 10.1021/acschembio.0c00546
  10. Pandey A, Vighetto V, Di Marzio N, Ferraro F, Hirsch M, Ferrante N, Mitra S, Grattoni A, Filgueira CS. Gold Nanoparticles Radio-Sensitize and Reduce Cell Survival in Lewis Lung Carcinoma. Nanomaterials 2020 Aug 30;10(9):E1717. doi: 10.3390/nano10091717
  11. Terracciano R, Sprouse ML, Wang D, Ricchetti S, Hirsch M, Ferrante N, Butler EB, Demarchi D, Grattoni A and Filgueira CS. Intratumoral Gold Nanoparticle-Enhanced CT Imaging: An in Vivo Investigation of Biodistribution and Retention. 2020 IEEE 20th International Conference on Nanotechnology (IEEE-NANO) Montreal, QC, Canada, 2020, 349353. doi: 10.1109/NANO47656.2020.9183611
  12. Di Trani N, Silvestri A, Bruno G, Geninatti T, Chua CYX, Gilbert A, Rizzo G, Filgueira CS, Demarchi D, Grattoni A. Remotely controlled nanofluidic implantable platform for tunable drug delivery. Lab Chip. 2019 Jun 25;19(13):2192-2204. doi: 10.1039/c9lc00394k
  13. Filgueira CS*, Igo SR, Wang DK, Hirsch M, Schulz DG, Bruckner BA, Grattoni A. Technologies for intrapericardial delivery of therapeutics and cells. Adv. Drug Deliv. Rev. 2019 Feb 21. pii: S0169-409X(19)30022-5. doi: 10.1016/j.addr.2019.02.006.
  14. Di Trani N, Jain P, Chua CYX, Ho JS, Bruno G, Susnjar A, Pons-Faudoa FP, Sizovs A, Hood RL, Smith ZW, Ballerini A, Filgueira CS, Grattoni A. Nanofluidic microsystem for sustained intraocular delivery of therapeutics. Nanomedicine: nanotechnology, biology, and medicine 2018; Nov 22;16:1-9. doi: 10.1016/j.nano.2018.11.002.
  15. Chua C, Jain P, Ballerini A, Bruno G, Hood RL, Gupte M, Gao S, Di Trani N, Susnjar A, Shelton K, Bushman LR, Folci M, Filgueira CS, Marzinke MA, Anderson PL, Hu M, Nehete P, Arduino RC, Sastry JK, Grattoni A. Transcutaneously refillable nanofluidic implant achieves sustained level of tenofovir diphosphate for HIV pre-exposure prophylaxis. Journal of Controlled Release. 2018; Sept 28; 286, 315-325. doi: 10.1016/j.jconrel.2018.08.010.
  16. Chua C, Jain P, Susnjar A, Rhudy J, Folci M, Ballerini A, Gilbert A, Singh S, Bruno G, Filgueira CS, Yee C, Butler E, Grattoni A. Nanofluidic drug-eluting seed for sustained intratumoral immunotherapy in triple negative breast cancer. Journal of Controlled Release. 2018 September 10; 285:23-34. doi: 10.1016/j.jconrel.2018.06.035.
  17. Filgueira CS*, Bruno G, Smith ZW, Chua CYX, Ballerini A, Folci M, Gilbert AL, Jain P, Sastry JK, Nehete PN, Shelton KA, Hill LR, Ali A, Youker KA, Grattoni A. Efficacy of sustained delivery of GC-1 from a Nanofluidic system in a spontaneously obese non-human primate: a case study. Biomedical microdevices. 2018; 20(2):49. doi: 10.1007/s10544-018-0296-2.
  18. Bruno G, Di Trani N, Hood RL, Zabre E, Filgueira CS, Canavese G, Jain P, Smith Z, Demarchi D, Hosali S, Pimpinelli A, Ferrari M, Grattoni A. Unexpected behaviors in molecular transport through size-controlled nanochannels down to the ultra-nanoscale. Nature communications. 2018; 9(1):1682. doi: 10.1038/s41467-018-04133-8.
  19. Filgueira CS*, Ballerini A, Nicolov E, Chua CYX, Jain P, Smith ZW, Gilbert AL, Scaglione F, Grattoni A. A pharmacokinetic study of GC-1 delivery using a nanochannel membrane device. Nanomedicine. 2017; 13(5):1739-1744. doi: 10.1016/j.nano.2017.02.012.
  20. da Silva Teixeira S, Filgueira C, Sieglaff DH, Benod C, Villagomez R, Minze LJ, Zhang A, Webb P, Nunes MT. 3,5-diiodothyronine (3,5-T2) reduces blood glucose independently of insulin sensitization in obese mice. Acta physiologica. 2017; 220(2):238-250. doi: 10.1111/apha.12821
  21. Kelly AT, Filgueira CS, Schipper DE, Halas NJ, Whitmire KH. Gold coated iron phosphide core–shell structures RSC Adv. 2017; 7:25848-25854. doi: 10.1039/C7RA01195D
  22. Bruno G, Canavese G, Liu X, Filgueira CS, Sacco A, Demarchi D, Ferrari M, Grattoni A. The active modulation of drug release by an ionic field effect transistor for an ultra-low power implantable nanofluidic system. Nanoscale. 2016; 8(44):18718-18725. NIHMSID: NIHMS826263. doi: 10.1039/c6nr06235k
  23. Filgueira CS*, Nicolov E, Hood RL, Ballerini A, Garcia-Huidobro J, Lin JZ, Fraga D, Webb P, Sabek OM, Gaber AO, Phillips KJ, Grattoni A. Sustained zero-order delivery of GC-1 from a nanochannel membrane device alleviates metabolic syndrome. International journal of obesity. 2016; 40(11):1776-1783. doi: 10.1038/ijo.2016.129
  24. Sabek OM, Farina M, Fraga DW, Afshar S, Ballerini A, Filgueira CS, Thekkedath UR, Grattoni A, Gaber AO. Three-dimensional printed polymeric system to encapsulate human mesenchymal stem cells differentiated into islet-like insulin-producing aggregates for diabetes treatment. Journal of tissue engineering. 2016; 7: 2041731416638198. PMID: 27152147, PMCID: PMC4843232. doi: 10.1177/2041731416638198
  25. Ballerini A, Filgueira CS, Nicolov E, Jain P, Bruno G, Hood RL, Scaglione F, Grattoni A. Sustained Delivery of Tamoxifen from a Nanofluidic Delivery Platform. Drug delivery letters. 2016; 6(2):127-133. doi: 10.2174/2210303106666161129163850
  26. Puhl AC, Milton FA, Cvoro A, Sieglaff DH, Campos JC, Bernardes A, Filgueira CS, Lindemann JL, Deng T, Neves FA, Polikarpov I, Webb P. Mechanisms of peroxisome proliferator activated receptor γ regulation by non-steroidal anti-inflammatory drugs. Nuclear receptor signaling. 2015; 13:e004. PMID: 26445566, PMCID: PMC4594550; doi: 10.1621/nrs.13004
  27. Milton FA, Cvoro A, Amato AA, Sieglaff DH, Filgueira CS, Arumanayagam AS, de Lima Mdo C, Pitta IR, de Assis Rocha Neves F, Webb P. PPARγ partial agonist GQ-16 strongly represses a subset of genes in 3T3-L1 adipocytes. Biochemical and biophysical research communications. 2015; 464(3):718-23. PMID: 26168725. doi: 10.1016/j.bbrc.2015.07.011
  28. Filgueira CS*, Benod C, Lou X, Gunamalai PS, Villagomez RA, Strom A, Gustafsson JÅ, Berkenstam AL, Webb P. A screening cascade to identify ERβ ligands. Nuclear receptor signaling. 2014; 12:e003. PMID: 25422593, PMCID: PMC4242290. doi: 10.1621/nrs.12003
  29. Benod C, Villagomez R, Filgueira CS, Hwang PK, Leonard PG, Poncet-Montange G, Rajagopalan S, Fletterick RJ, Gustafsson JÅ, Webb P. The human orphan nuclear receptor tailless (TLX, NR2E1) is druggable. PloS one. 2014; 9(6):e99440. PMID: 24936658, PMCID: PMC4060991. doi: 10.1371/journal.pone.0099440
  30. Hester B, Campbell GK, López-Mariscal C, Filgueira CL, Huschka R, Halas NJ, Helmerson K. Tunable optical tweezers for wavelength-dependent measurements. The Review of scientific instruments. 2012; 83(4):043114. PMID: 22559522, PMCID: PMC3350537. doi: 10.1063/1.4704373
  31. Souza G, Stark D, Filgueira C, Raphael R, Killian T. Culturing Human Primary Lung Cells at the Air-Media Interface with Magnetic Levitation. Biophysical journal. 2011 February 02; 100(3):369a. doi: 10.1016/j.bpj.2010.12.2201
  32. Souza GR, Molina JR, Raphael RM, Ozawa MG, Stark DJ, Levin CS, Bronk LF, Ananta JS, Mandelin J, Georgescu MM, Bankson JA, Gelovani JG, Killian TC, Arap W, Pasqualini R. Three-dimensional tissue culture based on magnetic cell levitation. Nature nanotechnology. 2010; 5(4):291-6. NIHMSID: NIHMS700773, PMID: 20228788, PMCID: PMC4487889. doi: 10.1038/nnano.2010.23
  33. Kundu J, Levin CS, Halas NJ. Real-time monitoring of lipid transfer between vesicles and hybrid bilayers on Au nanoshells using surface enhanced Raman scattering (SERS). Nanoscale. 2009; 1(1):114-7. PMID: 20644868. doi: 10.1039/b9nr00063a
  34. Levin CS*, Kundu J, Barhoumi A, Halas NJ. Nanoshell-based substrates for surface enhanced spectroscopic detection of biomolecules. The Analyst. 2009; 134(9):1745-50. PMID: 19684894. doi: 10.1039/b909080k
  35. Levin CS*, Hofmann C, Ali TA, Kelly AT, Morosan E, Nordlander P, Whitmire KH, Halas NJ. Magnetic-plasmonic core-shell nanoparticles. ACS nano. 2009; 3(6):1379-88. NIHMSID: NIHMS117755, PMID: 19441794, PMCID: PMC4108303. doi: 10.1021/nn900118a
  36. Brinson BE, Lassiter JB, Levin CS, Bardhan R, Mirin N, Halas NJ. Nanoshells made easy: improving Au layer growth on nanoparticle surfaces. Langmuir : the ACS journalof surfaces and colloids. 2008; 24(24):14166-71. NIHMSID: NIHMS91202, PMID: 19360963, PMCID: PMC5922771. doi: 10.1021/la802049p
  37. Levin CS*, Kundu J, Janesko BG, Scuseria GE, Raphael RM, Halas NJ. Interactions of ibuprofen with hybrid lipid bilayers probed by complementary surface-enhanced vibrational spectroscopies. The journal of physical chemistry. B. 2008; 112(45):14168-75. NIHMSID: NIHMS91078, PMID: 18942873, PMCID: PMC4886502. doi: 10.1021/jp804374e
  38. Lal S, Grady NK, Kundu J, Levin CS, Lassiter JB, Halas NJ. Tailoring plasmonic substrates for surface enhanced spectroscopies. Chemical Society reviews. 2008; 37(5):898-911. PMID: 18443675. doi: 10.1039/b705969h
  39. Choi MR, Stanton-Maxey KJ, Stanley JK, Levin CS, Bardhan R, Akin D, Badve S, Sturgis J, Robinson JP, Bashir R, Halas NJ, Clare SE. A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors. Nano letters. 2007; 7(12):3759-65. PMID: 17979310. doi: 10.1021/nl072209h
  40. Ward DR, Grady NK, Levin CS, Halas NJ, Wu Y, Nordlander P, Natelson D. Electromigrated nanoscale gaps for surface-enhanced Raman spectroscopy. Nano letters. 2007; 7(5):1396-400. PMID: 17430009. doi: 10.1021/nl070625w
View All Publications